Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms

This study is for patients with breast cancer at treatment time point of using a medication type called aromatase inhibitors. The drug anastrozole will be used. The effects that this drug has on the patient and whether genetics plays a part in how this drug effects patients will be studied. Muscle and joint aches, AIMSS(aromatase inhibitor-associated musculoskeletal syndrome), specifically will be studied. This study will also monitor the effects of hormone therapy on the patient's quality of life and willingness to continue treatment.
Content from General Links with modal content